Celltrion Pharm

068760.KQ

35.35 USD

0.14

+0.40%

Overview

Last close

35.35 usd

Market cap

1.57B usd

52 week high

52.45 usd

52 week low

30.18 usd

Target price

91.22 usd

Valuation

P/E

N/A

Forward P/E

49.505

Price/Sales

8.4968

Price/Book Value

5.456

Enterprise Value

1.63B usd

EV/Revenue

4.5172

EV/EBITDA

30.8156

Key financials

Revenue TTM

184.28M usd

Gross Profit TTM

54.22M usd

EBITDA TTM

28.71M usd

Earnings per Share

N/A usd

Dividend

0.13 usd

Total assets

526.39M usd

Net debt

63.86M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.